DIVI'S LABORATORIES LTD.

NSE : DIVISLABBSE : 532488ISIN CODE : INE361B01024Industry : Pharmaceuticals & DrugsHouse : Divis Labs
BSE3779.059.3 (+0.25 %)
PREV CLOSE ( ) 3769.75
OPEN PRICE ( ) 3771.00
BID PRICE (QTY) 3776.20 (1)
OFFER PRICE (QTY) 3779.05 (2)
VOLUME 1125
TODAY'S LOW / HIGH ( )3767.35 3787.25
52 WK LOW / HIGH ( )3050.15 4072.35
NSE3780.0011.35 (+0.3 %)
PREV CLOSE( ) 3768.65
OPEN PRICE ( ) 3779.65
BID PRICE (QTY) 3780.05 (5)
OFFER PRICE (QTY) 3782.20 (3)
VOLUME 7997
TODAY'S LOW / HIGH( ) 3765.55 3788.00
52 WK LOW / HIGH ( )3051 4074.4
Exchange
Period From    
Period To    
Exchange Deal Date Client Name Tran Qty (000's) Trade Price () Value (Rs.in Lakhs) Close Price ()

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.